IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 320 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

DRUG WATCH

Sitagliptin-induced hemolysis

Bekur Ragini, Nagaraja M V, Shivashankara K N, Stanley Weena

Year : 2010| Volume: 42| Issue : 5 | Page no: 320-321

   This article has been cited by
 
1 Challenge of diabetes mellitus and researchers’ contributions to its control
Ayodele T. Odularu, Peter A. Ajibade
Open Chemistry. 2021; 19(1): 614
[Pubmed]  [Google Scholar] [DOI]
2 Sensitive detection of quinoline-derivatized sitagliptin in small volumes of human plasma by MALDI-TOF mass spectrometry
Yi-Shan Li, Wei-Lung Tseng, Chi-Yu Lu
Talanta. 2020; 218: 121143
[Pubmed]  [Google Scholar] [DOI]
3 DPP-4 inhibitors: a patent review (2012 – 2014)
Roberto Costante,Azzurra Stefanucci,Simone Carradori,Ettore Novellino,Adriano Mollica
Expert Opinion on Therapeutic Patents. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Dipeptidyl peptidase-4 inhibitors: Multitarget drugs, not only antidiabetes drugs
Yunjuan Zhao,Lin Yang,Zhiguang Zhou
Journal of Diabetes. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
5 Erythrocyte mechanical fragility is increased in patients with type 2 diabetes
Lippi, G., Mercadanti, M., Aloe, R., Targher, G.
European Journal of Internal Medicine. 2012; 23(2): 150-153
[Pubmed]  [Google Scholar]
6 Erythrocyte mechanical fragility is increased in patients with type 2 diabetes
Giuseppe Lippi,Mariella Mercadanti,Rosalia Aloe,Giovanni Targher
European Journal of Internal Medicine. 2012; 23(2): 150
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow